RBT creates personalized cancer vaccines for animals

RBT is launching the production of a set for creating personalized vaccines for the treatment of cancer in small pets. RBT vaccines activate the pet's immune system to fight the tumor. Currently, there are only two solutions in the line: a set for creating a personalized multi-antigen vaccine against lymphomas in cats and dogs, and a set with the Betusfera adjuvant. Testing of the sets in veterinary clinics will last up to 3 months. After that, the industrial prototype will be developed into a finished product.